Group items tagged

How does a person feel when he lost his eyes in an accident or when one of his legs amputated? Would he feel like to end his life to escape from the crises or try to face all the problems that come on his way? According to the statistics more than one million people in the world commit suicide per year and over thirty thousand of these are said to be from the United States. Why these people commit suicide? What demoralize them? The surveys says that people commit suicide for different reasons in which most common are financial problems, relationship problems, bullying and stress of work. These people are trapped in depression and make up their mind that things will never get better, and none can improve the situation. G. B. Shaw said, "Sometimes, people get attached to their burdens more than the burdens are attached to them." Life gets tough We all just have to admit that life can sometimes get tough! Our health may sometimes suffer, family demands demoralize, daily traumas build up and work strains speed up, but it doesn't mean to feel that the life isn't worth living. In such situation, we need a dose of inspiration that makes us feel good.Buy online wheelchair for handicapped and disabled at lowest Wheelchair price and cheap cost in india from wheelchair india online shopping. Inspiration brings positive signs and heightens our creativity. In times of insecurity, remind yourself of those who overcame bodily limitations and various obstructions. Finding inspiration Here are six inspirational stories of people who, in spite of their physical limitations, participated fully in all aspects of the society. These differently-abled people (I don't like to say them disable) are not only inspirational to other people having physical problems; but equally inspirational to those of us who feel life is worthless and give up trying when the obstacles come on our way. One of the world's best-known overachiever Stephen Hawking who suffers from Mot

Supplements became hugely popular in the last decade to treat deficiencies and boost various body functions. People who work out use supplements to promote muscle growth and gain energy during exercise. If you are suffering from hormone or vitamin deficiency, you can get off-the-shelf supplements to get your daily intake of these vitamins. However, there have been cases where some people became too reliant on supplements and started taking more than the required dose. Although most of them are made from natural ingredients, it's not particularly safe to use any supplement before understanding what it is and if you actually need it. Here are a few things you need to know before taking supplements or pill products. SUPPLEMENTS DON'T REPLACE A HEALTHY LIFESTYLE Taking supplements every day doesn't mean you are leading a healthy lifestyle. Supplements support this lifestyle but they're not the basis of being healthy. If someone doesn't exercise, eats junk food all the time, and smokes heavily, taking supplements will not make them live or feel better. It all starts with leading a healthy lifestyle, and if you want to boost body function or treat a deficiency, then supplements will have the desired effect. EVERYONE IS DIFFERENT There is no magic solution that works for everyone on the planet. What worked for your friend may not necessarily work for you. Popping a pill or drinking a supplement shake won't improve your performance unless you are taking the right supplement for what you need to be targeted. For instance, vitamin B12 comes from meat, fish, and dairy foods, so vegans should look for a supplement that will provide them with this vitamin.

Pets are not just making the house became more lively or as a "guard" the house. Keeping animals was also able to help make us healthier. What are the effects of raising animals in the house? Push intelligence Research found that having a pet helps children read better, and even help a child's cognitive, too.

Eating out in fast food centers with high fat foods such as burgers and pizzas became the rage of the age as these foods were tasty and easily available too.

Recently, in Rebel wilson Instagram post, her fans were surprised to see her totally new look. She lost around 35 pounds within a span of a few months. And suddenly people started approaching her to know her weight loss story. She became an inspiration for all the plus size women.

Then surfing became my favorite pass time.At times i thought,i was getting addicted to it.But gradually as time went on i learned to create a balance between my day job and blogging.

https://www.mymedistore.com/product/cimivir-400-mg/ Buy Cimivir 400 mg Online - Order Cheapest Cimivir 400 mg from Mymedistore- your most reliable online pharmacy. Avail best price in USA, by your doorsteps.

https://misoprostolhotline.com/cara-pakai-cytotec-misoprostol/ misoprostolhotline : call 08574 0559 466. Jual Obat Cytotec di Jakarta Bandung.Jogjakarta

Britain will start to roll out Merck's molnupiravir Covid-19 antiviral pill through a drug trial later this month, Susan Hopkins, chief medical adviser at the UK Health Security Agency said on Sunday (November 7). Last week Britain became the first country in the world to approve the potentially game-changing Covid-19 antiviral pill, jointly developed by US-based Merck & Co Inc and Ridgeback Biotherapeutics. The government said in October it had secured 480,000 courses of the Merck drug, as well as 250,000 courses of an antiviral pill developed by Pfizer Inc. Asked about the molnupiravir approval, Hopkins told BBC television: "That is great news and it will start to be rolled out through a drug trial in the end of this month/the beginning of December." Hopkins said all the trials so far had been done with the unvaccinated, so this would help understand how it will work in the wider vaccinated population.

A pair of pharmacist brothers, who also own a popular restaurant in Kent, have started an innovative initiative 'Jabs with Kebabs' to encourage their community in England to come forward and take their Covid-19 vaccines. Rav and Raj Chopra, who own V's Punjabi Grill, an Indian restaurant in Gravesend, established the walk-in vaccine site after their father, Jagtar Chopra, became unwell with Covid-19 last year. The duo is among thousands to volunteer for the National Health Service (NHS) vaccine programme. Talking to the PA news agency, Raj said he was inspired by the experience of his father, who got infected with the virus and has fully recovered since then. "From a personal point of view, it was very debilitating to see Dad like that," said Raj Chopra. "It got everyone's emotions in play.

Health services in the UK today (January 4) marked the first anniversary of the deployment of the Oxford University/AstraZeneca vaccine in fight against Covid-19. Exactly a year ago, the UK became the first country in the world to administer the vaccine by jabbing Brian Pinker, 82 at Oxford University Hospital. So far, around 50 million AstraZeneca vaccines have been administered to people in the UK. Commenting on the landmark day, vaccines minister Maggie Throup said: "The Oxford-AstraZeneca vaccine is a UK success story and demonstrates what can be achieved when researchers, scientists and the government work together. "The at-cost vaccine has given billions of people around the world a way to fight back against this virus." Further, she urged people to get vaccinated to protect themselves and their families this winter.

Researchers from the University of Oxford today (December 8) started recruiting for a clinical trial to test novel antiviral Covid-19 treatments for early use in the illness by people in the community and those who are at higher risk of complications. Partnering with the National Institute for Health Research (NIHR), colleagues in several UK universities, and the NHS UK-wide, the Platform Adaptive trial of NOvel antiviRals for eArly treatMent of Covid-19 In the Community (PANORAMIC), is a national priority trial, and will be open to participants from across the UK. The first treatment to be tested by the UK Antiviral Taskforce will be molnupiravir, a Covid antiviral pill already licensed by the MHRA. Britain became the first country in the world to approve molnupiravir, which was jointly developed by U.S.-based Merck & Co Inc and Ridgeback Biotherapeutics, in November.

The Association of the British Pharmaceutical Industry (ABPI) has welcomed the National Institute for Health and Care Excellence's leadership in introducing a new approach to the evaluation of antibiotics. On Tuesday (12 April), NICE published a draft guidance to tackle antimicrobial resistance under which two new antimicrobial drugs - cefiderocol and ceftazidime-avibactam - became the first to be made available as part of the UK's innovative subscription-style payment model. Commenting on the announcement of the new draft guidance, Richard Torbett, chief executive of the ABPI, said: "This is an important milestone in the UK's global leadership on AMR. Antibiotics underpin modern medicine, but the increasing threat of antibiotic resistance remains one of the biggest global health challenges we face. "To tackle this, it is critical that the appropriate frameworks are in place for companies to invest the billions of pounds required to discover the new antibiotics needed for patients.

The Competition Appeal Tribunal (CAT) has upheld the Competition and Markets Authority's (CMA) findings against two pharmaceutical manufacturers who consistently overcharged hydrocortisone tablets for over a decade. Auden/Actavis UK's pricing for the critical medicine 'hydrocortisone' from 2008 to 2018 constituted an abuse of their dominant market position, leading to fines nearing £130 million, CMA said in a statement. "These companies increased the price of this crucial medicine by over 10,000 per cent, soaring from 70p to £72 within that period. These are the highest ever CMA penalties upheld by the Tribunal," the CMA said. In July 2021, the CMA imposed fines exceeding £265 million on hydrocortisone manufacturers Auden Mckenzie and Actavis UK, which acquired Auden's business in 2015 and subsequently became Accord-UK. The fines were imposed for abuse of dominance and collusion by both the parent companies and potential competitors. The recent verdict, announced on September 18, comes five weeks after the Tribunal supported the CMA's decision in a separate case regarding the pricing of medicines supplied to the NHS. In that prior case, fines amounted to £84 million.

A member of the English Pharmacy Board and RPS Assembly, Sharon Isobel Tait Buckle (also known as Sibby) has been elected unopposed as the treasurer of the Royal Pharmaceutical Society (RPS). Sibby takes over the role from Andre Yeung, whose tenure ended in June 2022. Sibby was first elected to the English board in 2012 and is the first woman to hold the post since RPS became the professional leadership body in 2010. She is already part of the Finance and Investment Committee, where RPS budgets, pensions, assets, financial priorities and performance, reserves and investment policies are scrutinised and agreed. Commenting on her new role, Buckle said: "I want to build on the great contribution made by our previous Treasurer. Over the next two years of my tenure I will monitor and challenge our financial performance, our focus on Environmental, Social and Governance factors (ESG), investment strategy and performance and our financial governance.

Britain's Covid booster campaign is set to kick off this September, after the country became the first in the world to approve an Omicron-adapted shot. Around 26 million people in Britain are estimated to be eligible for an autumn Covid-19 booster, having had at least two Covid vaccine doses already, a UK Health Security Agency (UKHSA) spokesperson said. The preference is to deploy what is known as a "bivalent vaccine" that targets both the original virus and the Omicron variant through the autumn campaign, but that will depend on the health regulator (MHRA) approving such shots and the state of vaccine supplies. The UK's Joint Committee on Vaccination and Immunisation (JCVI) has advised boosters should be given to over-50s, individuals in clinical risk groups, frontline workers and care-home staff ahead of the winter, when respiratory viruses are typically at their peak. On Monday (August 15), the MHRA gave Moderna's bivalent shot conditional approval. The endorsement of the vaccine is based on data that showed it produced a marginally better immune response against some Omicron variants, versus the original novel coronavirus - although whether that translates into stronger protection against serious disease is unclear.

In his maiden speech delivered to community pharmacy since becoming new minister with responsibility for the sector, Will Quince MP said he's determined to be "your champion" and "voice in government". Addressing delegates on Wednesday (Oct 12) as chief guest at the 22nd Pharmacy Business Awards in central London, he praised community pharmacy for delivering 25 million Covid-19 vaccines, five million flu jabs, 200 million lateral flow testing kits and millions of medicines throughout the pandemic. "These local efforts became the national success story," he told over 600 attendees at a gala dinner held at the iconic Park Plaza Westminster Bridge hotel overlooking the Houses of Parliament. 'We need you now' Quince, who was appointed minister of state at the Department of Health and Social Care on 7 September 2022, added: "Just as we needed you in the pandemic, we need you now," highlighting the vital role of community pharmacy in realising the secretary of state (Thérèse Coffey)'s vision, particularly in regard to her much talked about 'Plan for Patients'.

The British Generic Manufacturers Association (BGMA) has elected Diane DiGangi Trench to be its new vice-chair. DiGangi Trench takes up the position replacing Xiromed's Peter Ballard and in 12-months' time will assume the association's chair role from Accord's Peter Kelly. With over 25 years of pharmaceutical industry experience, DiGangi Trench has held a number of senior commercial roles including stints with Takeda and Astra Zeneca. She joined Sandoz in 2018 in the US, where she served as Vice-President, Market Access and Patient Services. In 2021, she became the head of Sandoz' UK business and in her two years in role, she has led the organisation through a post-COVID recovery and growth phase to prepare for the proposed spin out of the company from its parent, Novartis, expected later this year. She said: "It's a great honor to take on the role of Vice Chair of the BGMA. The success of the generics and biosimilar industry is essential to the functioning of the NHS. Generic medicines fill four out of five UK prescriptions and biosimilars enable the NHS to expand access to more patients. I am passionate about increasing the sustainability of our industry so we can continue to play our vital part in the health of the nation." Mark Samuels, BGMA chief executive, said: "We are extremely fortunate to be able to call upon the expertise of Diane who has already added significant value through her role on the BGMA board and leadership of a key strategic committee.

Fife-based trainee pharmacist and Honorary Secretary of the PDA LGBT+ Network, Soh Xi Ken has won the Scottish Trades Union Congress' (STUC) Equality Award. One of Scotland's leading LGBT+ campaigners and Honorary Secretary of the PDA's LGBT+ Network has been recognised for his advocacy work for LGBT+ pharmacists in Scotland. Soh Xi Ken of the PDA received the Equality Award at the STUC Annual Congress in April 2023 in Dundee. The award praised Xi Ken's tireless advocacy for LGBT+ workers within pharmacies in Scotland, highlighting his personal experience of homophobia in Scotland and his home country, Malaysia. In May 2021, Xi Ken became a founding member of the PDA LGBT+ Network's committee and was elected as their first Honorary Secretary. The PDA LGBT+ Network is the first of its kind in the pharmacy world and has made a significant difference to the profile of LGBT+ people in the profession. Xi Ken and others within the PDA LGBT+ Network spotted that there was a lack of LGBT+-specific guidance given to pharmacy students and that their unique and specific health needs were not being addressed as part of the pharmacy education that they received.

HRA Pharma is celebrating the 1st anniversary of Hana, the first type of daily oral contraception available in the UK without a prescription. The launch of Hana in 2021 followed the historic decision of the Medicines and Healthcare products Regulatory Agency (MHRA) to grant a marketing authorisation and marked a significant step forward in the women's contraception category. The company reports that pharmacists have embraced the reclassification and have found merit in using emergency contraception consultations as an opportunity to educate women on their over-the-counter contraception options. Alison Slingsby, innovations project manager at HRA Pharma, commented: "We have been delighted with Hana's reception - within weeks of launch, it quickly became the best-selling mini-pill without prescription, with more than 95 per cent market share, and has maintained this market leading position ever since. We previously had the experience of switching emergency contraceptive ellaOne to a P medicine, Hana is on track to match and eventually exceed the ellaOne volumes.

A community pharmacist was applauded for his 'quick-thinking' action in treating a Co Down woman with a fatal bee sting. Joan Johnson, from Moira, was stung on her scalp in her home garden. After the bite, she noticed allergic reactions on her neck and ears with severe itching and redness. However, she was advised to visit her local pharmacy by the GP where the pharmacist, Stephen Joyce, quickly administered life-saving antihistamine and an adrenaline injection while an ambulance was called. Joan hailed the 'treatment' and the 'professionalism' of the whole team for saving her life. "What was just a simple bee-sting, quickly became something very serious. On arrival at the pharmacy on the advice from my GP, I was dealt with very promptly and Stephen was summoned and immediately took control of the situation. "I was given an urgent antihistamine, but quickly started feeling lightheaded and faint. The pharmacy team assisted me to a chair and called an ambulance," she said.

Wales launched the new electronic prescribing service (EPS) last week, with the country's first electronic prescription sent and dispensed on 17 November. The new service allows prescriptions to be sent digitally to a patient's nominated pharmacy, thus eliminating the need for paper forms. It is part of a wider plan to introduce digital medicines and e-prescribing in all hospitals and primary care in the country. Wellington Road Pharmacy and Lakeside Medical Centre in Rhyl became the first community pharmacy and GP practice to use the EPS, which is expected to be rolled out across Wales in January 2024.